Cerebral Blood Flow During CPB During Cardiac Surgery and the Presence of Post op Delirium

February 5, 2016 updated by: Dr Kaushik Mandal, Johns Hopkins University

Non Invasive Monitoring of Cerebral Blood Flow During and After Cardiopulmonary Bypass to Assess and Compare for the Presence of Delirium in Post Operative Patients (DELIRIUM)

Cardiac surgery is associated with multiple events and issues that increase risk for adverse postoperative neurological outcomes including postoperative cognitive dysfunction. The risk for postoperative delirium is generally thought to result from some previous health factors added to the susceptibility of the cardiac surgery process.

Study Overview

Status

Completed

Conditions

Detailed Description

Cardiac surgery is associated with multiple perturbations that increase risk for adverse postoperative neurological outcomes including postoperative cognitive dysfunction. These same perturbations likely also increase the risk for postoperative delirium although there are little data that have evaluated this hypothesis.

As the subject is prepared for surgery 2 contact probes will be placed on the forehead to monitor the rSO2 and cerebral blood flow. This monitor can also measureblood flow velocity in blood vessels in the forehead.

This will only be done while the subject is on the cardiac bypass machine during the surgery and end shortly after entering the intensive care unit.Prior to surgery and then once a day on three of the first four postoperative days, patients will be assessed for the presence and severity of delirium with brief standard psychological exams. We will compare rSO2 and CBF changes between patients with and without delirium

Study Type

Observational

Enrollment (Actual)

110

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21287
        • Johns Hopkins Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects who are under going cardiac bypass surgery with the use of cardiac perfusion

Description

Inclusion Criteria:

  • Patients in the study will be 50 or older undergoing elective cardiovascular surgery using cardiopulmonary bypass.
  • Patients who can speak, read and understand the English language.
  • Patients who understand the nature of the study and are willing to sign the consent form

Exclusion Criteria:

  • Emergency surgery or patients intubated before surgery and, thus, cannot give informed consent.
  • Patients diagnosed with neurocognitive disorders (e.g. Alzheimer's, Dementia)
  • MMSE score greater than 21 Patients taking antipsychotic drugs A history of drug abuse
  • Patients with an implant in the brain underneath the CerOx probes
  • Women who are pregnant.
  • History of significant, prohibitive skin allergies or reactions-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
no intervention
Contact with enrolled subjects requires application of ceberal oximetry electrodes and the concommittent ultrasound of the temporal artery. Deemed interventional by JHUIRB but no actual intervention done to subject.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate whether rSO2 and/or CBF during CPB is lower in patients who experience delirium within three days after cardiac surgery compared with patients without delirium
Time Frame: 3 days post op
To evaluate whether rSO2 and/or CBF during CPB is lower in patients who experience delirium within three days after cardiac surgery compared with patients without delirium.
3 days post op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
recovery pattern of rSO2
Time Frame: 3 post op days
To evaluate the recovery pattern of rSO2 and CBF for up to 6 hrs after CPB for ICU patients who experience delirium within three days after cardiac surgery compared with patients without delirium.
3 post op days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Can CBF autoregulation can be monitored using ultrasound compared with TCD
Time Frame: 3 days post op
To assess whether CBF autoregulation can be monitored using ultrasound tagged light methodology compared with TCD
3 days post op
To evaluate the incidence of delirium in patients with impaired autoregulation
Time Frame: 3 days post op
To evaluate the incidence of delirium in patients with impaired autoregulation
3 days post op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kaushik Mandal, MD, Johns Hopkins University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

February 25, 2014

First Submitted That Met QC Criteria

March 7, 2014

First Posted (Estimate)

March 12, 2014

Study Record Updates

Last Update Posted (Estimate)

February 9, 2016

Last Update Submitted That Met QC Criteria

February 5, 2016

Last Verified

February 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Subscribe